Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report)’s stock price shot up 7.8% on Wednesday . The company traded as high as $0.20 and last traded at $0.19. 19,100 shares changed hands during trading, a decline of 88% from the average session volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Trading Up 7.8 %
The stock’s fifty day simple moving average is $0.19 and its two-hundred day simple moving average is $0.19. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.04.
About Vyant Bio
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
Further Reading
- Five stocks we like better than Vyant Bio
- High Flyers: 3 Natural Gas Stocks for March 2022
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
- What is an Earnings Surprise?
- Power Play: Japan’s Top Auto Stocks Eye Historic Merger
- What Are Trending Stocks? Trending Stocks Explained
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
